Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8) , 1078-1081
- https://doi.org/10.1016/s0959-8049(05)80291-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- The role of the MDR1 (p-glycoprotein) gene in multidrug resistance in vitro and in vivoBiochemical Pharmacology, 1992
- Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-ACytotechnology, 1992
- Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpressionBritish Journal of Cancer, 1991
- Involvement of Vacuolar H+-Adenosine Triphosphatase Activity in Multidrug Resistance in HL60 CellsJNCI Journal of the National Cancer Institute, 1991
- Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionBritish Journal of Cancer, 1991
- Acid phosphatase: Endpoint for in vitro toxicity testsIn Vitro Cellular & Developmental Biology – Animal, 1991
- Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissuesBiochimica et Biophysica Acta (BBA) - General Subjects, 1991
- Over-expression of MDR gene with no dna amplification in a multiple-drug-resistant human ovarian carcinoma cell lineInternational Journal of Cancer, 1989